Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acyclovir for recurrent erythema multiforme caused by herpes simplex.

J C Huff1

  • 1Department of Dermatology, University of Colorado Health Sciences Center, Denver 80262.

Journal of the American Academy of Dermatology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examination of the oral mucosa and peripheral blood cells of patients with recurrent aphthous ulceration for human herpesvirus DNA.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics·2000
Same author

Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis.

Archives of dermatology·1998
Same author

A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis.

Journal of the American Academy of Dermatology·1998
Same author

Misdiagnosis, treatments, and outcomes in the immunobullous diseases in children.

Pediatric dermatology·1997
Same author

Intraepidermal neutrophilic IgA dermatosis in a patient with advanced human immunodeficiency virus infection.

Archives of dermatology·1997
Same author

Lesion size is a factor for determining the rate of port-wine stain clearing following pulsed dye laser treatment in adults.

Cutis·1997
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Journal of the American Academy of Dermatology·2026
Same journal

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Journal of the American Academy of Dermatology·2026
Same journal

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Journal of the American Academy of Dermatology·2026
Same journal

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal of the American Academy of Dermatology·2026
See all related articles

Continuous suppressive oral acyclovir effectively controls herpes-associated erythema multiforme. However, acyclovir is ineffective once herpes simplex recurrence is evident or erythema multiforme has already occurred.

Area of Science:

  • Dermatology
  • Virology
  • Immunology

Background:

  • Herpes-associated erythema multiforme (HAEM) is a significant clinical concern.
  • Recurrent herpes simplex virus (HSV) infections are known triggers for HAEM.
  • Current treatment strategies for HAEM are limited.

Purpose of the Study:

  • To evaluate the efficacy of oral acyclovir in controlling HAEM.
  • To determine the optimal timing for acyclovir administration in preventing HAEM.
  • To explore the role of topical acyclovir in HAEM prevention.

Main Methods:

  • Retrospective analysis of patient data.
  • Review of treatment protocols for oral and topical acyclovir.
  • Correlation of HSV recurrence timing with HAEM onset.

Related Experiment Videos

Main Results:

  • Continuous suppressive oral acyclovir treatment effectively controls HAEM.
  • Acyclovir administered after evident HSV recurrence or after HAEM onset is ineffective.
  • The efficacy of continuous topical acyclovir for HAEM prevention requires further investigation.
  • HAEM can be triggered by HSV recurrences at various body sites.

Conclusions:

  • Prophylactic continuous oral acyclovir is crucial for managing HAEM.
  • Timely intervention with acyclovir before HSV recurrence is key.
  • Further research is needed to confirm the role of topical acyclovir in HAEM prevention.